181 related articles for article (PubMed ID: 10835464)
1. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat.
Reglodi D; Somogyvari-Vigh A; Vigh S; Kozicz T; Arimura A
Stroke; 2000 Jun; 31(6):1411-7. PubMed ID: 10835464
[TBL] [Abstract][Full Text] [Related]
2. Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.
Tamás A; Reglõdi D; Szántó Z; Borsiczky B; Németh J; Lengvári I
Neuro Endocrinol Lett; 2002 Jun; 23(3):249-54. PubMed ID: 12080287
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions.
Reglodi D; Somogyvari-Vigh A; Vigh S; Maderdrut JL; Arimura A
Ann N Y Acad Sci; 2000; 921():119-28. PubMed ID: 11193815
[TBL] [Abstract][Full Text] [Related]
4. Multimodal neuroprotection induced by PACAP38 in oxygen-glucose deprivation and middle cerebral artery occlusion stroke models.
Lazarovici P; Cohen G; Arien-Zakay H; Chen J; Zhang C; Chopp M; Jiang H
J Mol Neurosci; 2012 Nov; 48(3):526-40. PubMed ID: 22678884
[TBL] [Abstract][Full Text] [Related]
5. Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri.
Schäbitz WR; Hoffmann TT; Heiland S; Kollmar R; Bardutzky J; Sommer C; Schwab S
Stroke; 2001 May; 32(5):1226-33. PubMed ID: 11340238
[TBL] [Abstract][Full Text] [Related]
6. Effect of middle cerebral artery occlusion on the passage of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier in the rat.
Somogyvári-Vigh A; Pan W; Reglödi D; Kastin AJ; Arimura A
Regul Pept; 2000 Jul; 91(1-3):89-95. PubMed ID: 10967205
[TBL] [Abstract][Full Text] [Related]
7. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
8. Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats.
Xu L; Fagan SC; Waller JL; Edwards D; Borlongan CV; Zheng J; Hill WD; Feuerstein G; Hess DC
BMC Neurol; 2004 Apr; 4():7. PubMed ID: 15109399
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
10. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
Pei Z; Pang SF; Cheung RT
Stroke; 2003 Mar; 34(3):770-5. PubMed ID: 12624306
[TBL] [Abstract][Full Text] [Related]
11. Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.
Reglodi D; Tamás A; Somogyvári-Vigh A; Szántó Z; Kertes E; Lénárd L; Arimura A; Lengvári I
Peptides; 2002 Dec; 23(12):2227-34. PubMed ID: 12535703
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
13. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide.
Uchida D; Arimura A; Somogyvári-Vigh A; Shioda S; Banks WA
Brain Res; 1996 Oct; 736(1-2):280-6. PubMed ID: 8930334
[TBL] [Abstract][Full Text] [Related]
14. Is an intravenous bolus injection required prior to initiating slow intravenous infusion of PACAP38 for prevention of neuronal death induced by global ischemia? The possible presence of a binding protein for PACAP38 in blood.
Somogyvári-Vigh A; Svoboda-Teet J; Vigh S; Arimura A
Ann N Y Acad Sci; 1998 Dec; 865():595-600. PubMed ID: 9928076
[No Abstract] [Full Text] [Related]
15. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system.
Zhang Y; Pardridge WM
Stroke; 2001 Jun; 32(6):1378-84. PubMed ID: 11387502
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
Stroke; 2003 Jun; 34(6):1507-12. PubMed ID: 12738892
[TBL] [Abstract][Full Text] [Related]
17. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.
Callaway JK; Knight MJ; Watkins DJ; Beart PM; Jarrott B
Stroke; 1999 Dec; 30(12):2704-12; discussion 2712. PubMed ID: 10583001
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of endothelin type A receptor antagonist on brain edema and injury after transient middle cerebral artery occlusion in rats.
Matsuo Y; Mihara Si ; Ninomiya M; Fujimoto M
Stroke; 2001 Sep; 32(9):2143-8. PubMed ID: 11546909
[TBL] [Abstract][Full Text] [Related]
19. PACAP38 differentially effects genes and CRMP2 protein expression in ischemic core and penumbra regions of permanent middle cerebral artery occlusion model mice brain.
Hori M; Nakamachi T; Shibato J; Rakwal R; Tsuchida M; Shioda S; Numazawa S
Int J Mol Sci; 2014 Sep; 15(9):17014-34. PubMed ID: 25257527
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular injection of human prostatic acid phosphatase has potent neuroprotective effects against transient focal cerebral ischemia in rats.
Yang Y; Bai X; Dong H; Lu Y; Xiong L
Neurosci Lett; 2011 Oct; 504(3):321-4. PubMed ID: 21982807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
